Combination of NK Cells and Cetuximab to Enhance Anti-Tumor Responses in RAS Mutant Metastatic Colorectal Cancer.
Veluchamy, John Pradeep
Combination of NK Cells and Cetuximab to Enhance Anti-Tumor Responses in RAS Mutant Metastatic Colorectal Cancer. [electronic resource] - PloS one 2016 - e0157830 p. digital
Publication Type: Journal Article
1932-6203
10.1371/journal.pone.0157830 doi
Antibodies, Monoclonal, Humanized--administration & dosage
Caco-2 Cells
Cell Proliferation--drug effects
Cell- and Tissue-Based Therapy
Cetuximab--administration & dosage
Colorectal Neoplasms--drug therapy
ErbB Receptors--antagonists & inhibitors
HT29 Cells
Humans
Immunoglobulin G--immunology
Killer Cells, Natural
Mutation
Neoplasm Metastasis
Proto-Oncogene Proteins B-raf--genetics
ras Proteins--genetics
Combination of NK Cells and Cetuximab to Enhance Anti-Tumor Responses in RAS Mutant Metastatic Colorectal Cancer. [electronic resource] - PloS one 2016 - e0157830 p. digital
Publication Type: Journal Article
1932-6203
10.1371/journal.pone.0157830 doi
Antibodies, Monoclonal, Humanized--administration & dosage
Caco-2 Cells
Cell Proliferation--drug effects
Cell- and Tissue-Based Therapy
Cetuximab--administration & dosage
Colorectal Neoplasms--drug therapy
ErbB Receptors--antagonists & inhibitors
HT29 Cells
Humans
Immunoglobulin G--immunology
Killer Cells, Natural
Mutation
Neoplasm Metastasis
Proto-Oncogene Proteins B-raf--genetics
ras Proteins--genetics